The structure of pathogenic huntingtin exon 1 defines the bases of its aggregation propensity
- PMID: 36864173
- DOI: 10.1038/s41594-023-00920-0
The structure of pathogenic huntingtin exon 1 defines the bases of its aggregation propensity
Abstract
Huntington's disease is a neurodegenerative disorder caused by a CAG expansion in the first exon of the HTT gene, resulting in an extended polyglutamine (poly-Q) tract in huntingtin (httex1). The structural changes occurring to the poly-Q when increasing its length remain poorly understood due to its intrinsic flexibility and the strong compositional bias. The systematic application of site-specific isotopic labeling has enabled residue-specific NMR investigations of the poly-Q tract of pathogenic httex1 variants with 46 and 66 consecutive glutamines. Integrative data analysis reveals that the poly-Q tract adopts long α-helical conformations propagated and stabilized by glutamine side chain to backbone hydrogen bonds. We show that α-helical stability is a stronger signature in defining aggregation kinetics and the structure of the resulting fibrils than the number of glutamines. Our observations provide a structural perspective of the pathogenicity of expanded httex1 and pave the way to a deeper understanding of poly-Q-related diseases.
© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.
Similar articles
-
The folding equilibrium of huntingtin exon 1 monomer depends on its polyglutamine tract.J Biol Chem. 2018 Dec 21;293(51):19613-19623. doi: 10.1074/jbc.RA118.004808. Epub 2018 Oct 12. J Biol Chem. 2018. PMID: 30315108 Free PMC article.
-
Molecular basis of Q-length selectivity for the MW1 antibody-huntingtin interaction.J Biol Chem. 2023 Apr;299(4):104616. doi: 10.1016/j.jbc.2023.104616. Epub 2023 Mar 16. J Biol Chem. 2023. PMID: 36931390 Free PMC article.
-
The Nt17 Domain and its Helical Conformation Regulate the Aggregation, Cellular Properties and Neurotoxicity of Mutant Huntingtin Exon 1.J Mol Biol. 2021 Oct 15;433(21):167222. doi: 10.1016/j.jmb.2021.167222. Epub 2021 Sep 4. J Mol Biol. 2021. PMID: 34492254
-
Proteostasis of Huntingtin in Health and Disease.Int J Mol Sci. 2017 Jul 19;18(7):1568. doi: 10.3390/ijms18071568. Int J Mol Sci. 2017. PMID: 28753941 Free PMC article. Review.
-
Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.Lancet Neurol. 2020 Nov;19(11):930-939. doi: 10.1016/S1474-4422(20)30343-4. Lancet Neurol. 2020. PMID: 33098802 Review.
Cited by
-
Comparative molecular dynamics simulations of pathogenic and non-pathogenic huntingtin protein monomers and dimers.Front Mol Biosci. 2023 Apr 10;10:1143353. doi: 10.3389/fmolb.2023.1143353. eCollection 2023. Front Mol Biosci. 2023. PMID: 37101557 Free PMC article.
-
Alternative low-populated conformations prompt phase transitions in polyalanine repeat expansions.Nat Commun. 2024 Mar 2;15(1):1925. doi: 10.1038/s41467-024-46236-5. Nat Commun. 2024. PMID: 38431667 Free PMC article.
-
The molecular basis for cellular function of intrinsically disordered protein regions.Nat Rev Mol Cell Biol. 2024 Mar;25(3):187-211. doi: 10.1038/s41580-023-00673-0. Epub 2023 Nov 13. Nat Rev Mol Cell Biol. 2024. PMID: 37957331 Free PMC article. Review.
-
A glutamine-based single α-helix scaffold to target globular proteins.Nat Commun. 2022 Nov 18;13(1):7073. doi: 10.1038/s41467-022-34793-6. Nat Commun. 2022. PMID: 36400768 Free PMC article.
-
Weighted families of contact maps to characterize conformational ensembles of (highly-)flexible proteins.Bioinformatics. 2024 Nov 1;40(11):btae627. doi: 10.1093/bioinformatics/btae627. Bioinformatics. 2024. PMID: 39432675 Free PMC article.
References
-
- Benn, C. L. et al. Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington’s disease. Hum. Mol. Genet. 14, 3065–3078 (2005).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
